Key result
Antiplatelet therapy is evolving toward multiple-drug regimens and personalized dose adjustments to address variable laboratory responses and improve clinical outcomes in cardiovascular disease.
Design
Review
Authors
Loading...
Hypothesis-generating for personalized antiplatelet regimens in CVD; prospective trials needed before clinical adoption.
Antiplatelet therapy is evolving towards multiple-drug regimens and personalized dose adjustments to balance efficacy and bleeding risk.
Varon et al. (2009) conducted a review in Arterial thrombosis and cardiovascular disease. Antiplatelet agents was evaluated. Antiplatelet therapy is evolving toward multiple-drug regimens and personalized dose adjustments to address variable laboratory responses and improve clinical outcomes in cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: